Tag: Healthcare industry news
Alignment Healthcare Stays as Health Insurers Flee JPM
Alignment Healthcare Stands Strong Amidst Industry TurmoilIn the midst of the chaos at the J.P. Morgan Healthcare Conference, one company stands out - Alignment...
Patrizia Cavazzoni Departs FDA’s Drug Center: What it Means for the Agency
Patrizia Cavazzoni’s Departure and Its Implications for the FDAPatrizia Cavazzoni, the esteemed leader of the Food and Drug Administration’s Center for Drug Evaluation and...
Navigating Pharma’s Patent Cliff: Impact on Obesity Fundraising and ALS Research
Navigating Pharma's Patent Cliff: Impact on Obesity Fundraising and ALS ResearchIn the fast-paced world of biotech, the looming patent cliff is causing a stir...
Insurance Profits and Denials Blamed for UHC CEO Death, Poll Reveals
UnitedHealthcare CEO Brian Thompson's tragic death on December 4th has sparked a nationwide conversation about the complex web of factors that may have played...
PhRMA Membership Dues Drop by Nearly $100 Million due to Major Drugmakers Exiting
PhRMA Membership Dues Plummet by $100 Million After Major Drugmakers ExitIn a significant blow to the Pharmaceutical Research and Manufacturers of America (PhRMA), three...
Centene Cancels Investor Day Event After UnitedHealthcare CEO Tragedy
Centene Shifts Investor Day Event Online Following UnitedHealthcare CEO TragedyCentene, a prominent health insurer, has made the difficult decision to transition its upcoming investor...
Sutter Health CEO Donates to Harris in Wake of Antitrust Investigation
Sutter Health's CEO, Warner Thomas, recently made significant donations to Vice President Harris' presidential campaign and the Democratic National Committee. Despite Harris' involvement in...
Roivant Sells Dermatology Spinoff to Organon in $1.2B Deal
Roivant Sciences, a prominent player in the biotech industry, has once again demonstrated its prowess in dealmaking by announcing the sale of one of...
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
